Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2016-01-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development and Validation of a Deep Learning System for Multiple Ocular Fundus Diseases Using Retinal Images
NCT04213430
AI Classifies Multi-Retinal Diseases
NCT04592068
Artificial Intelligence for Detecting Retinal Diseases
NCT04678375
An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings
NCT06918028
Explainable Ocular Fundus Diseases Report Generation System
NCT05622565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Construction of Dr intelligent grading diagnosis system based on fundus image: firstly, the fundus image is used as the fundus data training database, and according to the international clinical Dr grading diagnosis standard, many doctors mark the fundus image accurately. International clinical Dr grading criteria: grade 0, no obvious retinal abnormalities; grade 1, only microangioma; grade 2, more severe than microangioma, but less severe than severe; grade 3, four quadrants, each quadrant has more than 20 retinal hemorrhage, more than two quadrants have definite venous beads, more than one quadrant has obvious Irma, no signs of proliferative retinopathy; grade 4, neovascularization, vitreous hemorrhage Volume blood, pre retinal hemorrhage. On the basis of Dr grading intelligent diagnosis standard, convolution neural network is constructed to train and grade fundus images. After repeating this process many times for each image in the training set of fundus images, the deep learning system learns how to classify all the data in the training set to accurately diagnose the fundus images.
3. Convolution neural network construction for FFA image focus area: the convolution neural network of deep learning is composed of millions of parameters, which is used to train and perform given tasks. The output generated by each linear convolution operation is regularized by nonlinear activation function, combined with the dimensionality reduction of pooling layer and full connection layer, so that the optimization process of deep neural network not only overcomes the gradient dispersion, but also helps to generate features similar to the hierarchical perception mechanism of human neural cells to visual signals. The FFA image is used as the fundus data training database. Based on the accurate labeling of the lesion area (no perfusion area, microangioma area and leakage area), the FFA image needs to be treated for the intelligent recognition of the lesion area. In the training process, the parameters of the neural network are initially set to random values. Then, for each image, the results given by the function are compared with the known results of the training set to optimize the parameters of the function. After repeating this process many times for each image in the training data set, the deep learning system learned how to classify all the data in the training set to accurately predict the Dr lesions on FFA images.
4. Construction of intelligent fundus laser navigation model based on FFA image and fundus image registration: the Dr lesion intelligent recognition system on the above FFA image accurately identifies the areas that need fundus laser treatment, helps doctors determine the lesions that need to be treated, and based on the image matching of machine learning, provides the registration image of fundus image and FFA combination, which is set according to the location and size information of the lesion area According to the matching retinal diameter and the arrangement of different laser spots, the personalized laser treatment scheme is formulated, and the intelligent fundus laser treatment guidance model is constructed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients
patients with retinal diseases
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jin Kai, MD
Role: PRINCIPAL_INVESTIGATOR
Zhejiang University
Xu Yufeng, MD
Role: PRINCIPAL_INVESTIGATOR
Zhejiang University
Lou Lixia, MD
Role: PRINCIPAL_INVESTIGATOR
Zhejiang University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Second Affiliated Hospital of Zhejiang University
Hanzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jin Kai, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
研2019-428
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.